Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Congestive heart failure and arrhythmia]

H Kasanuki1

  • 1Department of Cardiology, Tokyo Women's Medical College.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 1, 1993
PubMed
Summary

Congestive heart failure (CHF) patients face high cardiac death risk from ventricular tachyarrhythmia. Advanced treatments like amiodarone and implantable cardioverter-defibrillators offer improved sudden death prevention strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Third heart sound in hospitalised patients with acute heart failure: insights from the ATTEND study.

International journal of clinical practice·2014
Same author

Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.

Heart (British Cardiac Society)·2008
Same author

[Surgical treatment of Marfan syndrome; late results and new strategy].

Kyobu geka. The Japanese journal of thoracic surgery·2002
Same author

Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.

Journal of cardiovascular pharmacology and therapeutics·2002
Same author

Retinoic acid suppresses endothelin-1 gene expression at the transcription level in endothelial cells.

Atherosclerosis·2001
Same author

Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan.

Japanese circulation journal·2001

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Ventricular tachyarrhythmia is a significant cause of cardiac mortality in congestive heart failure (CHF) patients.
  • Approximately 40% of cardiac deaths in CHF are attributed to ventricular tachyarrhythmia.

Purpose:

  • To review current understanding and treatment strategies for ventricular arrhythmia in CHF.
  • To highlight advancements in antiarrhythmic drug therapy and device implantation for sudden cardiac death prevention.

Summary:

  • Class I antiarrhythmic drugs exhibit proarrhythmic and negative inotropic effects.
  • Class III agents, particularly amiodarone, show promise in preventing sudden death.
  • Therapeutic advancements include beta-blockers, ACE inhibitors, and implantable cardioverter-defibrillators (ICDs).

Impact:

  • Improved management of ventricular arrhythmias in CHF patients.
  • Enhanced strategies for preventing sudden cardiac death in this vulnerable population.
  • Guidance for clinicians on selecting appropriate therapies for CHF-associated arrhythmias.

Related Experiment Videos